NO963526L - N-metyl-N-£(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etyl|-2,2-difenylacetamid - Google Patents

N-metyl-N-£(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etyl|-2,2-difenylacetamid

Info

Publication number
NO963526L
NO963526L NO963526A NO963526A NO963526L NO 963526 L NO963526 L NO 963526L NO 963526 A NO963526 A NO 963526A NO 963526 A NO963526 A NO 963526A NO 963526 L NO963526 L NO 963526L
Authority
NO
Norway
Prior art keywords
diphenylacetamide
hydroxypyrrolidine
phenyl
ethyl
methyl
Prior art date
Application number
NO963526A
Other languages
English (en)
Other versions
NO307048B1 (no
NO963526D0 (no
Inventor
Inge Stein
Holger Beeres
Klaus Beschmann
Steffen Neuenfeld
Andrew Barber
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963526D0 publication Critical patent/NO963526D0/no
Publication of NO963526L publication Critical patent/NO963526L/no
Publication of NO307048B1 publication Critical patent/NO307048B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO963526A 1995-08-26 1996-08-23 N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)- etyl]-2,2-difenylacetamidhydroklorid, legemiddel som inneholder forbindelsen, anvendelse av legemidlet til fremstilling av legemiddelpreparater, farmasøytiske preparater som inneholder l NO307048B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19531464A DE19531464A1 (de) 1995-08-26 1995-08-26 N-Methyl-N-[(1S-)-1-phenyl-2-((3S)-3-hydroxypyrrolidin 1-yl-)-ethyl]-2,2-diphenyl-acetamid

Publications (3)

Publication Number Publication Date
NO963526D0 NO963526D0 (no) 1996-08-23
NO963526L true NO963526L (no) 1997-02-27
NO307048B1 NO307048B1 (no) 2000-01-31

Family

ID=7770485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963526A NO307048B1 (no) 1995-08-26 1996-08-23 N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)- etyl]-2,2-difenylacetamidhydroklorid, legemiddel som inneholder forbindelsen, anvendelse av legemidlet til fremstilling av legemiddelpreparater, farmasøytiske preparater som inneholder l

Country Status (25)

Country Link
US (1) US6060504A (no)
EP (1) EP0761650B1 (no)
JP (3) JP5023273B2 (no)
KR (1) KR100436254B1 (no)
CN (1) CN1081631C (no)
AR (1) AR004679A1 (no)
AT (1) ATE207895T1 (no)
AU (1) AU716615B2 (no)
BR (1) BR9603540A (no)
CA (1) CA2184049C (no)
CZ (1) CZ287783B6 (no)
DE (2) DE19531464A1 (no)
DK (1) DK0761650T3 (no)
ES (1) ES2165948T3 (no)
HU (1) HU226667B1 (no)
MX (1) MX9603606A (no)
NO (1) NO307048B1 (no)
PL (1) PL187691B1 (no)
PT (1) PT761650E (no)
RU (1) RU2174976C2 (no)
SI (1) SI0761650T1 (no)
SK (1) SK282437B6 (no)
TW (1) TW513407B (no)
UA (1) UA41978C2 (no)
ZA (1) ZA967200B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032096A1 (en) * 1997-12-22 1999-07-01 Alza Corporation Novel formulations for the transdermal administration of asimadoline
DE19827633A1 (de) * 1998-04-20 1999-10-21 Merck Patent Gmbh Verfahren zur Herstellung von enantiomerenreinem N-Methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamid
US6174878B1 (en) * 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain
DE10116978A1 (de) * 2001-04-05 2002-10-10 Merck Patent Gmbh Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
EP1505974B1 (en) * 2002-05-17 2009-04-22 Tioga Pharmaceuticals, Inc. Use of compounds that are effective as selective opiate receptor modulators
DE10259245A1 (de) * 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
WO2005046687A1 (en) * 2003-10-30 2005-05-26 Tioga Pharmaceuticals, Inc. Use of selective opiate receptor modulators in the treatment of neuropathy
ES2393815T3 (es) 2007-03-30 2012-12-28 Tioga Pharmaceuticals, Inc. Agonistas opioides kappa para el tratamiento de síndrome del intestino irritable con diarrea predominante y alternante
EP2284987B1 (en) * 2009-08-12 2019-02-06 Braun GmbH Method and device for adjusting the frequency of a drive current of an electric motor
WO2011136905A2 (en) * 2010-04-07 2011-11-03 Onyx Therapeutics, Inc. Crystalline peptide epoxyketone immunoproteasome inhibitor
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
CN103664727A (zh) * 2013-12-19 2014-03-26 无锡万全医药技术有限公司 一种一锅法制备1-[(3s)-3-羟基吡咯烷-1-基]-(2s)-2-甲氨基-2-苯基乙烷的工艺
ES2906979T3 (es) * 2016-12-21 2022-04-21 Tioga Pharmaceuticals Inc Formulaciones farmacéuticas sólidas de asimadolina
EP3932390A1 (en) 2020-07-02 2022-01-05 Dr. August Wolff GmbH & Co. KG Arzneimittel Topical gel formulation containing asimadoline

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide

Also Published As

Publication number Publication date
KR970010744A (ko) 1997-03-27
TW513407B (en) 2002-12-11
DK0761650T3 (da) 2002-02-18
JP5023273B2 (ja) 2012-09-12
HUP9602346A2 (en) 1997-09-29
AU6214996A (en) 1997-03-06
MX9603606A (es) 1997-03-29
HU9602346D0 (en) 1996-10-28
AR004679A1 (es) 1999-03-10
EP0761650A1 (de) 1997-03-12
CZ243496A3 (en) 1997-03-12
DE59608050D1 (de) 2001-12-06
JPH09110830A (ja) 1997-04-28
PL315799A1 (en) 1997-03-03
RU2174976C2 (ru) 2001-10-20
ES2165948T3 (es) 2002-04-01
HU226667B1 (en) 2009-06-29
EP0761650B1 (de) 2001-10-31
SI0761650T1 (en) 2002-04-30
SK108996A3 (en) 1997-06-04
BR9603540A (pt) 1998-05-12
AU716615B2 (en) 2000-03-02
PL187691B1 (pl) 2004-09-30
PT761650E (pt) 2002-04-29
ATE207895T1 (de) 2001-11-15
JP2012246321A (ja) 2012-12-13
JP2009046501A (ja) 2009-03-05
US6060504A (en) 2000-05-09
CZ287783B6 (en) 2001-02-14
UA41978C2 (uk) 2001-10-15
CN1151986A (zh) 1997-06-18
CA2184049C (en) 2007-10-02
CN1081631C (zh) 2002-03-27
NO307048B1 (no) 2000-01-31
NO963526D0 (no) 1996-08-23
KR100436254B1 (ko) 2005-01-25
DE19531464A1 (de) 1997-02-27
SK282437B6 (sk) 2002-02-05
CA2184049A1 (en) 1997-02-27
ZA967200B (en) 1997-03-03
HUP9602346A3 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
TR199600716A2 (tr) Siklik yapistirici inhibitörleri.
DE69630044D1 (de) Viren inaktivierende umhüllungen
DE69636353D1 (de) Datenübetragungsvorrichtung.
FI950715A0 (fi) Ytmikromekanisk, symmetrisk tryckskillnadsgivare
NO963526L (no) N-metyl-N-£(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etyl|-2,2-difenylacetamid
NO960499D0 (no) Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner
DK0874814T3 (da) 25-hydroxy-16-en-26,27-bishomo-cholecalciferoler
DE69621673D1 (de) (3S)-(6E)-2,3-Dihydrofarnesol enthaltendes Parfüm
IT1280362B1 (it) Pacchetto, particolarmente per sigarette
TR199601018A1 (tr) Farmasötik bilesikler.
ES1032571Y (es) Gafa,
NO982085L (no) Fremgangsmate for rensing av erytropoietiner.
ES1032948Y (es) Aplique.
UA10757A (uk) д.„Џ
ES1030777Y (es) Sobre-bolsa perfeccionado.
FI952416A0 (fi) Distributionsanordning foer vaetska, speciellt tvaettvaetska foer vindrutor
FI950956A0 (fi) Luftkabel, saosom haengspiralkabel
ES1031411Y (es) Embalaje.
ES1032150Y (es) Peldaño perfeccionado.
ES1030724Y (es) Embudo perfeccionado.
KR960030542U (ko) 팁, 담브
IT1276501B1 (it) Via tranviaria.
ES1030601Y (es) Radiador-convector, perfeccionado.
ES1031496Y (es) Horma perfeccionada.
ES1031199Y (es) Almohada magneto-terapeutica, perfeccionada.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees